This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Penny Stocks Get Delisting Warning

Nile Therapeutics (NLTX)

Closing Price: 32.7 cents (June 29)

Six-Month Stock Performance: -74.9%

Received Nasdaq Notice: June 1

Management's Expected Action: The biopharmaceutical company has until Nov. 29 to regain compliance with the minimum bid price requirement. Nile Therapeutics said it "intends to actively monitor the bid price" but "has not yet determined to take any other action in response to the notice." The stock had traded above $1 until late April, when Nile Therapeutics priced a public offering of 6.5 million units at 70 cents per unit. Each unit consisted of one share of Nile common stock and 0.30 warrant to purchase common stock. Proceeds from the offering will be used to fund the expansion of its ongoing Phase II clinical trial of CD-NP in acute heart failure patients, the company said. The stock slumped after the offering announcement and has yet to recover.
4 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABCW $47.86 0.00%
DYNT $2.88 0.00%
INSM $12.15 0.00%
OXGN $0.66 0.00%
USAT $4.38 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs